BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Modern Pathology Year : 2012

BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma.

Abstract

The angiogenic microenvironment has been known to be a component of angioimmunoblastic T-cell lymphoma since its initial characterization. We have shown that angioimmunoblastic T-cell lymphoma endothelial cells produce vascular endothelial growth factor-A (VEGFA), and participate in lymphoma progression. In squamous cell carcinoma, endothelial BCL2 expression induces a crosstalk with tumor cells through VEGFA, a major mediator of tumoral angiogenesis. In the present study, we analyzed BCL2 and VEGFA in 30 angioimmunoblastic T-cell lymphomas, using triple immunofluorescence to identify protein coexpression in well-characterized lymphoma cells and microenvironment neoangiogenic endothelial cells. Using quantitative real-time PCR, we assessed mRNA expression levels in laser-microdissected endothelial and lymphoma cells. In lymphoma cells, as in endothelial cells, BCL2 and VEGFA proteins were coexpressed. BCL2 was expressed only in neoangiogenic CD34(+)CD105(+) endothelial cells. In laser-microdissected cells, mRNA studies showed a significant relationship between BCL2 and VEGFA levels in CD34(+) endothelial cells, but not in CD3(+)CD10(+)lymphoma cells, or in CD34(+) endothelial cells from lymph node hyperplasia. Further study showed that, in AITL, BCL2 mRNA levels in CD34(+)CD105(+) neoangiogenic endothelial cells also correlated with microvessel density, International Prognostic Index, Ann Arbor stage, bone marrow involvement and elevated LDH. BCL2 expression by CD105(+) neoangiogenic endothelial cells is related to tumor progression in angioimmunoblastic T-cell lymphoma.
Fichier principal
Vignette du fichier
Ratajczak-submitted_revised_-Modern_Pathology.pdf (159 Ko) Télécharger le fichier
inserm-00682931_edited.pdf (440.99 Ko) Télécharger le fichier
Origin Files produced by the author(s)
Origin Files produced by the author(s)
Loading...

Dates and versions

inserm-00682931 , version 1 (10-08-2012)

Identifiers

Cite

Philippe Ratajczak, Christophe Leboeuf, Li Wang, Josette Brière, Irmine Loisel-Ferreira, et al.. BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma.. Modern Pathology, 2012, 25 (6), pp.805-14. ⟨10.1038/modpathol.2012.1⟩. ⟨inserm-00682931⟩

Collections

INSERM UNIV-PARIS7
111 View
606 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More